Discontinuation of Disease-Modifying Therapy for Patient with Relapsing-Remitting Multiple Sclerosis

被引:0
|
作者
Yano, Hajime [1 ,2 ]
Gonzalez, Cindy T. [1 ,2 ]
Healy, Brian C. [1 ,2 ]
Glanz, Bonnie I. [1 ,2 ]
Weiner, Howard L. [1 ,2 ]
Chitnis, Tanuja [3 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Partners Multiple Sclerosis Ctr, Boston, MA 02115 USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Partners MS Ctr, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P061
引用
收藏
页码:47 / 47
页数:1
相关论文
共 50 条
  • [1] Disease-modifying therapy in adult relapsing-remitting multiple sclerosis
    Rosenzweig, Tamara M.
    Hartman, Sarah
    MacKenzie, Elizabeth
    FORMULARY, 2010, 45 (08) : 252 - 262
  • [2] Disease-modifying therapies in relapsing-remitting multiple sclerosis
    Gonzalez-Andrade, Fabricio
    Luis Alcaraz-Alvarez, Jose
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 365 - 373
  • [3] Disease-modifying therapy in relapsing-remitting multiple sclerosis: efficacy is paramount
    Cristiano, E
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, : 3 - 7
  • [4] Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes
    Yano, Hajime
    Gonzalez, Cindy
    Healy, Brian C.
    Glanz, Bonnie, I
    Weiner, Howard L.
    Chitnis, Tanuja
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 35 : 119 - 127
  • [5] Oral disease-modifying therapies for relapsing-remitting multiple sclerosis
    Thomas, Rachel Hutchins
    Wakefield, Richard A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (01) : 25 - 38
  • [6] Established disease-modifying treatments in relapsing-remitting multiple sclerosis
    Oh, Jiwon
    O'Connor, Paul W.
    CURRENT OPINION IN NEUROLOGY, 2015, 28 (03) : 220 - 229
  • [7] Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis
    Roos, I.
    Malpas, C.
    Leray, E.
    Casey, R.
    Horakova, D.
    Havrdova, E. Kubala
    Debouverie, M.
    Patti, F.
    De Seze, J.
    Izquierdo, G.
    Eichau, S.
    Edan, G.
    Prat, A.
    Girard, M.
    Ozakbas, S.
    Grammond, P.
    Zephir, H.
    Ciron, J.
    Maillart, E.
    Moreau, T.
    Amato, M. P.
    Labauge, P.
    Alroughani, R.
    Buzzard, K.
    Skibina, O.
    Terzi, M.
    Laplaud, D.
    Berger, E.
    Grand'Maison, F.
    Lebrun-Frenay, C.
    Cartechini, E.
    Boz, C.
    Lechner-Scott, J.
    Clavelou, P.
    Stankoff, B.
    Prevost, J.
    Kappos, L.
    Pelletier, J.
    Shaygannejad, V.
    Yamout, B.
    Gerlach, O.
    Spitaleri, D.
    van Pesch, V.
    Gout, O.
    Turkoglu, R.
    Heinzlef, O.
    Thouvenot, E.
    Vukusic, S.
    Butzkueven, H.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 673 - 676
  • [8] Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis
    Roos, I.
    Malpas, C. B.
    Leray, E.
    Buzzard, K.
    Skibina, O.
    Lechner-Scott, J.
    McCombe, P.
    Slee, M.
    Butler, E.
    Macdonell, R.
    van der Walt, A.
    Hodgkinson, S.
    Barnett, M.
    Vucic, S.
    Vukusic, S.
    Butzkueven, H.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 : 6 - 7
  • [9] Patient perspective on decisions to switch disease-modifying treatments in relapsing-remitting multiple sclerosis
    Manzano, A.
    Eskyte, I
    Ford, H. L.
    Pavitt, S. H.
    Potrata, B.
    Schmierer, K.
    Chataway, J.
    Webb, E. J. D.
    Meads, D.
    Pepper, G.
    Bekker, H. L.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [10] Injectable Disease-Modifying Therapy for Relapsing-Remitting Multiple Sclerosis: A Review of Adherence Data
    Caon, Christina
    Saunders, Carol
    Smrtka, Jennifer
    Baxter, Nancy
    Shoemaker, Jennifer
    JOURNAL OF NEUROSCIENCE NURSING, 2010, 42 (05) : S5 - S9